Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: Relevance of smoking, trauma and antiviral therapy

BMC Medicine

Volumn 8, Issue , 2010, Pages

  Parruti, Giustino ^a   Tontodonati, Monica ^a   Rebuzzi, Cristina ^a   Polilli, Ennio ^a   Sozio, Federica ^a   Consorte, Augusta ^a   Agostinone, Adriana ^a   Di Masi, Francesco ^a   Congedo, Gabriele ^a   D'Antonio, Domenico ^a   Granchelli, Carla ^c   D'Amario, Claudio ^c   Carunchio, Carlo ^b   Pippa, Lucio ^b   Manzoli, Lamberto ^d   Volpi, Antonio ^e  

^a Pescara General Hospital   (Italy)

^b Fondazione Onlus Camillo de Lellis per l'Innovazione e la Ricerca in Medicina   (Italy)

^c Pescara Health District   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIVIRAL THERAPY; ARTICLE; CIGARETTE SMOKING; FEMALE; HERPES ZOSTER; HUMAN; INCIDENCE; INJURY; ITALY; MAJOR CLINICAL STUDY; MALE; PAIN; POSTHERPETIC NEURALGIA; AGED; AREA UNDER THE CURVE; COHORT ANALYSIS; MIDDLE AGED; PAIN ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SMOKING; TIME;

ANTIVIRUS AGENT;

ADULT; AGED; ANTIVIRAL AGENTS; AREA UNDER CURVE; COHORT STUDIES; FEMALE; HERPES ZOSTER; HUMANS; ITALY; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SMOKING; TIME FACTORS; WOUNDS AND INJURIES;

EID: 77957661958     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-58     Document Type: Article

References (52)

1. Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJM, Stalman WAB, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 2002, 19:471-475. 10.1093/fampra/19.5.471, 12356697.
2. di Luzio Paparatti U, Arpinelli F, Visonà G. Herpes zoster and its complications in Italy: an observational survey. J Infect 1999, 38:116-120. 10.1016/S0163-4453(99)90079-8, 10342652.
3. Chidiac C, Bruxelle J, Daures JP, et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001, 33:62-69. 10.1086/320884, 11389496.
4. Hegalson S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a single episode of herpes zoster: prospective study with long term follow up. BMJ 2000, 321:1-4. 10.1136/bmj.321.7252.1, 1127674, 10875807.
5. Gauthier A, Breuer J, Carrington D, Martin M, Rémy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009, 137:38-47. 10.1017/S0950268808000678, 18466661.
6. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007, 82:1341-1349. 10.4065/82.11.1341, 17976353.
7. Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005, 20:748-753. 10.1111/j.1525-1497.2005.0150.x, 1490195, 16050886.
8. Opstelten W, van Wijck AJM, van Essen GA, et al. The PINE study: rationale and design of randomised comparison of epidural injection of local anaesthetics and steroids versus care-as-usual to prevent postherpetic neuralgia in the elderly. BMC Anesthesiology 2004, 4:2. 10.1186/1471-2253-4-2, 341453, 15005813.
9. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007, 44:S1-26. 10.1086/510206, 17143845.
10. Volpi A, Gatti A, Serafini G, et al. Clinical and psychosocial correlates of acute pain in herpes zoster. J Clin Virol 2007, 38:275-279. 10.1016/j.jcv.2007.01.010, 17339131.
11. Opstelten W, van Loon AM, van Wijck AJM, Moons KGM. Correlates of acute pain in herpes zoster. J Clin Virol 2007, 39:238-239. 10.1016/j.jcv.2007.04.020, 17556015.
12. Dworkin RH, Nagasako EM, Johnson RW, Griffin DR. Acute pain in herpes zoster: the famciclovir database project. Pain 2001, 94:113-119. 10.1016/S0304-3959(01)00347-5, 11576750.
13. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996, 67:241-51. 10.1016/0304-3959(96)03122-3, 8951917.
14. Watson CPN, Oaklander AL. Postherpetic neuralgia. Pain Practice 2002, 2:295-307. 10.1046/j.1533-2500.2002.02039.x, 17156037.
15. Niv D, Maltsman-Tseikhin A. Postherpetic neuralgia: the never-ending challenge. Pain Practice 2005, 5:327-340. 10.1111/j.1533-2500.2005.00035.x, 17177766.
16. Thyregod HG, Rowbotham MC, Peters M, Possehn J, Berro M, Petersen KL. Natural history of pain following herpes zoster. Pain 2006, 128:148-156. 10.1016/j.pain.2006.09.021, 1905461, 17070998.
17. Jung BF, Johnson RW, Griffin DRJ, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004, 62:1545-1551.
18. Scott FT, Leedham-Green ME, Barrett-Muir WY, Hawrami K, Gallagher WJ, Johnson R, Breuer J. A study of shingles and the development of postherpetic neuralgia in East London. J Med Virol 2003, 70:S24-30. 10.1002/jmv.10316, 12627483.
19. Nagasako EM, Johnson RW, Griffin DRJ, Dworkin RH. Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol 2002, 46:834-839. 10.1067/mjd.2002.120924, 12063479.
20. McKendrick MW, Ogan P, Care CC. A 9 year follow up of post herpetic neuralgia and predisposing factors in elderly patients following herpes zoster. J Infect 2009, 59:416-4-20. 10.1016/j.jinf.2009.09.008, 19766139.
21. Levin MJ, Gershon A, Dworkin RH, Briston M, Stanberry L. Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol 2010, 48:S14-S19. 10.1016/S1386-6532(10)70004-4, 20510262.
22. Thomas SL, Wheeler JG, Hall AJ. Case-control study of the effect of mechanical trauma on the risk of herpes zoster. BMJ 2004, 328:439-440. 10.1136/bmj.37991.511829.F7, 344263, 14742350.
23. Evans RW, Lee AG. Herpes zoster ophtalmicus, ophtalmoplegia and trauma. Headache 2004, 44:286-288. 10.1111/j.1526-4610.2004.04062.x, 15012669.
24. Foye PM, Stitik TP, Nadler SF, Chen B. A study of post-traumatic shingles as a work related injury. Am J Ind Med 2000, 38:108-111. 10.1002/1097-0274(200007)38:1<108::AID-AJIM12>3.0.CO;2-V, 10861772.
25. Levy JM, Smyth SH. Reactivation of herpes zoster after liver biopsy. J Vasc Interv Radiol 2002, 13:209-210. 10.1016/S1051-0443(07)61941-1, 11830629.
26. Godfrey EK, Brown C, Stambough JL. Herpes zoster--varicella complicating anterior thoracic surgery: 2 case reports. J Spinal Disord Tech 2006, 19:299-301. 10.1097/01.bsd.0000204499.76600.a5, 16778668.
27. Li Q, Chen N, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2009, CD006866.
28. Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? A systematic review of the literature. J Fam Pract 2000, 49:255-2-64.
29. Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol 1998, 83:148-156. 10.1016/S0165-5728(97)00231-2, 9610683.
30. Johnson G, Nelson S, Petric M, Tellier R. Comprehensive PCR-based assay for detection and identification of human herpesviruses. J Clin Microbiol 2000, 38:3274-3279. 87373, 10970370.
31. Sauerbrei A, Sommer M, Eichhorn U, Wutzler P. [Laboratory diagnosis of herpes zoster: virology or serology?]. Med Klin (Munich) 2002, 97:123-127. German, 10.1007/s00063-002-1135-y, 11957786.
32. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0. 2003, Publish Date: August 9, 2006. Last accessed May 4th, 2010., http://ctep.cancer.gov
33. Coplan PM, Schmader J, Nikas A, et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the Brief Pain Inventory. J Pain 2004, 5:344-356. 10.1016/j.jpain.2004.06.001, 15336639.
34. Hosmer DW, Lemeshow S. Applied Logistic Regression 2000, New York: John Wiley & Sons, 2.
35. Hamilton LC. Statistics with Stata (Updated for version 9) 2006, Belmont, CA: Thomson - Brooks/Cole.
36. Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE. Regression methods in biostatistics. Linear, Logistic, Survival, and Repeated Measures Models 2005, NY: Springer.
37. Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modelling using Stata, Second Edition 2008, College Station, TX, USA: Stata Press.
38. Rittger H, Rieber J, Breithardt OA, et al. Influence of age on pain perception in acute myocardial ischemia: A possible cause for delayed treatment in elderly patients. Int J Cardiol 2010,
39. Gibson SJ, Helme RD. Age-related differences in pain perception and report. Clin Geriatr Med 2001, 17:433-456. 10.1016/S0749-0690(05)70079-3, 11459714.
40. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 2009, 10:447-485. 10.1016/j.jpain.2008.12.001, 2677686, 19411059.
41. Weingarten TN, Moeschler SM, Ptaszynski AE, Hooten WM, Beebe TJ, Warner DO. An assessment of the association between smoking status, pain intensity, and functional interference in patients with chronic pain. Pain Physician 2008, 11:643-653.
42. Agrawal D, Vohra R, Gupta PP, Sood S. Subclinical peripheral neuropathy in stable middle-aged patients with chronic obstructive pulmonary disease. Singapore Med J 2007, 48:887-894.
43. Faden A, Mendoza E, Flynn F. Subclinical neuropathy associated with chronic obstructive pulmonary disease: possible role of smoking. Arch Neurol 1981, 38:639-642.
44. Mykletun A, Overland S, Aarø LE, Liabø HM, Stewart R. Smoking in relation to anxiety and depression: evidence from a large population survey: the HUNT study. Eur Psychiatry 2008, 23:77-84. 10.1016/j.eurpsy.2007.10.005, 18082377.
45. Volpi A, Pica F, Bellino S, Marsella LT, Sabato AF. Clinical and psychosocial correlates of post-herpetic neuralgia. J Med Virol 2008, 80:1646-1652. 10.1002/jmv.21254, 18649332.
46. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352:2271-2284. 10.1056/NEJMoa051016, 15930418.
47. Whitley RJ, Volpi A, McKendrick M, van Wijck A, Oaklander AL. Management of herpes zoster and post-herpetic neuralgia now and in the future. J Clin Virol 2010, 48:S20-S28. 10.1016/S1386-6532(10)70005-6, 20510264.
48. McGorry RW, Webster BS, Snook SH, Hsiang SM. Accuracy of pain recall in chronic and recurrent low back pain. J Occup Rehabil 1999, 9:169-178.
49. Houtveen JH, Oei NY. Recall bias in reporting medically unexplained symptoms comes from semantic memory. J Psychosom Res 2007, 62:277-282. 10.1016/j.jpsychores.2006.11.006, 17324676.
50. Dworkin RH, Carrington D, Cunningham A, Kost RG, Levin MJ, McKendrick MW, Oxman MN, Rentier B, Schmader KE, Tappeiner G, Wassilew SW, Whitley RJ. Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res 1997, 33:73-85. 10.1016/S0166-3542(96)01007-8, 9021049.
51. Opstelten W, McElhaney J, Weinberger B, Oaklander AL, Johnson RW. The impact of varicella zoster virus: chronic pain. J Clin Virol 2010, 48:S8-13. 10.1016/S1386-6532(10)70003-2, 20510265.
52. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000, 342:635-645. 10.1056/NEJM200003023420906, 10699164.